Premature Atrial Contraction Count Tied to Atrial Fibrillation Risk

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A recent study published in the Annals of Internal Medicine finds that premature atrial contraction count may improve atrial fibrillation risk model performance. The prospective cohort study examined the effect of premature atrial contraction count on atrial fibrillation risk model performance in patients with prevalent atrial fibrillation enrolled in the Cardiovascular Health Study. The results indicated that doubling the hourly premature atrial contraction count was related to a significant increase in the risk for atrial fibrillation and overall mortality. The researchers conclude that premature atrial contraction count offers greater atrial risk discrimination and improves risk reclassification.

To read the full article at HCPLive.com, click here.
Related Articles
The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
The largest and most recent analysis of digoxin has reaffirmed the drug’s association with a heightened risk of early death in patients with atrial fibrillation (AF) or congestive heart failure (CHF).
Pharmacist-driven drug management programs best ensure atrial fibrillation patients adhere to the warfarin alternative, dabigatran (Pradaxa).
Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$